Quick Look: The latest price of dacomitinib/dacomitinib in 2024

Dacomitinib/Dacomitinib (Dacomitinib) is a targeted therapy for non-small cell lung cancer (NSCLC). It mainly acts on the epidermal growth factor receptor (EGFR), blocking the growth and proliferation of tumor cells by inhibiting the kinase activity of this receptor. This drug is particularly suitable for patients with locally advanced or metastatic non-small cell lung cancer who have EGFR exon 19 deletion mutations or exon 21 L858R substitution mutations.

As a first-line treatment drug, dacomitinib tablets have shown good results in controlling the disease and prolonging survival of non-small cell lung cancer. However, during use, patients need to pay close attention to possible adverse reactions such as interstitial pneumonia, diarrhea, rash, etc., and conduct treatment under the guidance of a doctor.

Dacomitinib, an important original drug, has been launched in the domestic market and has been included in Class B medical insurance, making it affordable for more patients. Its common 15mg 30 tablet specification is sold in China for about more than 1,000 yuan. However, in overseas markets, especially in the European market, the price of the same drug for 30 tablets of 45 mg is as high as more than 20,000 yuan, and the price will fluctuate according to changes in exchange rates. But the good news is that there are cost-effective options in overseas markets. For example, the generic version of dacomitinib produced in Laos has a specification of 45mg*30 tablets and a price of only about 800 yuan. This is undoubtedly an affordable choice for patients who need long-term medication, although its price may also be affected by the exchange rate.

Overall, dacomitinib tablets provide a new treatment option for patients with non-small cell lung cancer and help improve patients’ prognosis and quality of life. However, treatment effects and side effects may vary depending on individual differences, so patients should take the medication under the guidance of a doctor.